ArticleAmerican journal on intellectual and developmental disabilities2020

Evaluating the Risks and Benefits of Genetic and Pharmacologic Interventions for Down Syndrome: Views of Parents.

Kirsten A Riggan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.